JTE-522. Antiinflammatory cyclooxygenase-2 inhibitor

Drugs of the Future

Volumn 23, Issue 6, 1998, Pages 598-601

  Silvestre, J ^a   Leeson, P A ^a   Castaner J ^a  

^a PROUS SCIENCE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ARACHIDONIC ACID; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; FLUFENAMIC ACID; GR 253035; HISTAMINE; IBUPROFEN; INDOMETACIN; MEFENAMIC ACID; MELOXICAM; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NABUMETONE; NAPROXEN; NIMESULIDE; PIROXICAM; PROSTACYCLIN DERIVATIVE; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; PYRIDINIUM DERIVATIVE; ROFECOXIB; TENIDAP; THROMBOXANE; TILMACOXIB; UNCLASSIFIED DRUG;

CLINICAL TRIAL; DOSE RESPONSE; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN; INFLAMMATION; NONHUMAN; ORAL DRUG ADMINISTRATION; OSTEOARTHRITIS; REVIEW; RHEUMATOID ARTHRITIS;

EID: 0031869577     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.1998.023.06.462862     Document Type: Review

References (20)

1. Haruta, J., Hashimoto, H., Matsushita, M. (Japan Tobacco, Inc.). Heteroaromatic oxazole cpds. and use thereof. EP 745596, EP 826676, JP 96325249, JP 97052882, WO 9619462, WO 9619463.
2. Vane, J. R. Towards a better aspirin. Nature 1994, 367: 215-6.
3. Needleman, P., Turk, J., Jakschik, B.A., Morrison, A.R., Lefkowith, J.B. Arachidonic acid metabolism. Ann Rev Biochem 1986, 55: 69-102.
4. Pairet, M., Engelhardt, G. Distinct isoforms (COX-1 and COX-2) of cyclooxygenase: Possible physiological and therapeutic implications. Fundam Clin Pharmacol 1996, 10: 1-15.
5. 2 synthase (cyclooxygenase) in human monocytes. J Biol Chem 1990, 265: 16737-40.
6. Xie, W., Chipman, J.G., Robertson, D.L., Erikson, R.L., Simmons, D.L. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA 1991, 88: 2692-6.
7. Meade, E.A., Smith, W.L., DeWitt, D.L. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem 1993, 268: 6610-4.
8. Brooks, P.M., Day, R.O. Nonsteroidal antiinflammatory drugs - Differences and similarities. New Engl J Med 1991, 324: 1716-25.
9. Clive, D.M., Stoff, J.S. Renal syndromes associated with non-steroidal antiinflammatory drugs. New Engl J Med 1984, 310: 563-72.
10. Matsushita, M., Masaki, M., Yagi, Y., Tanaka, T., Wakitani, K. Pharmacological profile of JTE-522, a novel prostaglandin H synthase-2 inhibitor, in rats. Inflamm Res 1997, 46: 461-6.
11. Matsushita, M., Masaki, M., Wakitani, K., Tanaka, T. Antiinflammatory, anti-pyretic and analgesic effects of JTE-522, a novel selective inhibitor of COX-2 in rats. Jpn J Pharmacol 1997, 73(Suppl. 1): Abst P-110.
12. Niki, H., Yamada, M., Yamaki, K., Mue, S., Ohuchi, K. Effects of JTE-522, a specific inhibitor of cyclooxygenase-2, on the recurrence of allergic inflammation in rats. Eur J Pharmacol 1998, 344: 261-7.
13. Hashimoto, H., Imamura, K., Wakitani, K., Haruta, J. Potent and selective COX-2 inhibitors. 214th ACS Natl Meet (Sept 7-11, Las Vegas) 1997, Abst MEDI 090.
14. Masaki, M., Matsushita, M., Wakitani, K. Inhibitory effects of JTE-522, a novel prostaglandin H synthase-2 inhibitor, on adjuvant-induced arthritis and bone changes in rats. Inflamm Res 1998, 47: 187-92.
15. Nakano, H., Aizawa, H., Matsumoto, K., Fukuyama, S., Yoshida, M., Inoue, H., Koto, H., Hara, N. A selective COX-2 inhibitor, JTE-522 attenuates airway hyperresponsiveness but not inflammation after ozone exposure in guinea pigs. Amer J Respir Crit Care Med 1998, 157: A819.
16. Curnock, A.P., Robson, P.A., Yea, C.M., Moss, D., Gadher, S., Thomson, T.A., Westwood, R., Ruuth, E., Williamson, R.A. Potencies of leflunomide and HR325 as inhibitors of prostaglandin endoperoxide H synthase-1 and -2: Comparison with nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther 1997, 282: 339-47.
17. JT licenses new oral antiinflammatory agent to R.W. Johnson. Prous Science Daily Essentials November 26, 1997.
18. JTE-522 development status. R.W. Johnson Company Communication 1998, May 19.
19. Masaki, M., Matsushima, M., Yagi, Y., Wakitani, K. The pharmacological profile of JTE-522, a novel cyclooxygenase-2 inhibitor. Inflamm Res 1997, 46(Suppl. 3): Abst P-III-1-34.
20. Niki, H., Yamada, M., Yamaki, K., Mue, S., Ohuchi, K. Suppression of the recurrence of allergic inflammation in rats by JTE-522, a specific inhibitor of cyclooxygenase-2 in cell culture systems. Inflamm Res 1997, 46(Suppl. 3): Abst P-III-1-35.